Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

MatinasBioPharma's MAT-9001 superior to Vascepa in reducing blood lipid levels

June 3, 2015

Merck Serono signs collaboration agreement with Genea Biomedx for fertility technologies

June 2, 2015

Researchers describe the functional loss of HSD17B3 mutant G133R

June 2, 2015

European Commission approves intermittent use of Esmya for long-term management of uterine fibroids

May 29, 2015

Merck & Co. synthesizes antidiabetic FFAR1 agonists

May 29, 2015

The Scripps Research Institute receives NIH grant to study novel obesity pathway

May 29, 2015

Empagliflozin/metformin pill approved in E.U. for type 2 diabetes

May 29, 2015

Trelagliptin launched in Japan for type 2 diabetes

May 28, 2015

Synageva BioPharma files NDA for sebelipase alfa in Japan

May 27, 2015

Migalastat granted accelerated assessment by EMA for Fabry disease

May 27, 2015

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...